Clearmind Biomedical Signs Exclusive U.S. Distribution Agreement with Sutter Medical Technologies USA and launches the Neuroblade System at Congress of Neurological Surgeons (CNS) Los Angeles, CA. | P

Partnership Expands Access to Next-Generation Minimally Invasive Solution for Surgical Evacuation of Intracerebral Hemorrhage.

SAN JOSE, Calif. , Oct. 3, 2025 /PRNewswire/ -- Clearmind Biomedical, a leader in minimally invasive neurosurgical innovation, today announced it has signed an exclusive U.S. distribution agreement with Sutter Medical for the Neuroblade Multi-Function Neuro-Endoscope System, a 510(k)-cleared device engineered to advance the treatment of complex neurosurgical conditions such as intracerebral hemorrhage (ICH).